MBX Biosciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 44.9% | 44.9% | -38.7% |
| FY2024 | -24.1% | -24.1% | -23.1% |
| FY2025 | -23.6% | -23.6% | -22.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 44.9% | 44.9% | -38.7% |
| FY2024 | -24.1% | -24.1% | -23.1% |
| FY2025 | -23.6% | -23.6% | -22.6% |